Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Novo Nordisk announced it is making the popular weight loss medication available to three telehealth companies and revealed plans to make it more affordable for those paying out-of-pocket.

According to The New York Times, the most popular of the drugs ... approved to treat sleep apnea, Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss.

A sleep apnea drug is already available in the ... gut receptors to spark metabolic effects, such as weight loss. The way Zepbound works to treat OSA is unknown, but obesity is a risk factor ...

Medicare covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and ... access GLP-1s for weight loss. Meanwhile, the Food and Drug Administration ...

Sleep apnea is a common sleep disorder that causes abnormal breathing patterns as you sleep, like pauses in your breath.

The Massachusetts biotech reported May 19 that AD109 met the primary endpoint of a phase 3 trial, reducing sleep apnea ... drugs designed specifically to treat it. Eli Lilly’s weight loss ...

Weight loss drugs known as GLP1s are all the rage right now. They were originally developed for diabetes and weight management, but other "off label" uses are becoming more mainstream.